Join our daily newsletter At The Bell to receive exclusive market insights
The ASX200 has dropped further than futures had tipped. Down more than a per cent.
The only sectors in the green are IT – which has been boosted by Nasdaq mega-caps – and healthcare, which is barely there.
While iron ore has shed 2.25 per cent, it’s still at US$130 a tonne in the wake of Chinese property developer Evergrande’s liquidation last week amid $300 billion in debts.
Silver Lake Resources (ASX:SLR) is down nearly 12.5 per cent, while Red 5 (ASX:RED) is up nearly 2.3 per cent after the companies announced their intentions to merge.
In this bulletin, we will cover Pro Medicus, Unith, Bioxyne and Deep Yellow.
But first, Silver Lake shareholders are set to receive 3.43 Red 5 shares for every Silver Lake share they hold, securing 48.3 per cent ownership.
The deal would see a company producing 445 thousand ounces of gold for the 2024 financial year, with 4 million ounces of ore reserve.
Healthcare informatics giant, Pro Medicus (ASX:PME) has jumped nearly 5 per cent after announcing its wholly-owned US subsidiary, Visage Imaging, is launching its Visage Ease VP product for Apple’s new spatial computing program and virtual reality ‘Vision Pro’ headset.
Visage Ease VP has been purpose-built for the Apple ecosystem and this move will allow analysis of diagnostic images in a virtual environment.
PME shares have been trading at $109.81.
Meanwhile, AI digital avatar company, Unith (ASX:UNT) is raising $4.5 million to fund the company’s digital human rollout.
The small-cap disrupter has secured $2 million through a Placement and is raising a further $2.1 million via an Entitlement offer priced at 1.45 cents.
UNT shares have been trading at 1.7 cents today.
And medicinal company Bioxyne (ASX:BXN) has gained 50 per cent on market thanks to its subsidiary Breathe Life Sciences (BLS), securing a Therapeutic Goods Administration (TGA) Good Manufacturing Practice (GMP) license to manufacture cannabis, psilocybin and MDMA.
This year, Bioxyne plans to register the Psilocybin and MDMA capsules with the TGA for export to supply companies, universities, and clinical trials worldwide.
BXN shares have been trading at 1.4 cents.
Also today, uranium company Deep Yellow (ASX:DYL) has been trading down close to four per cent despite announcing it’s expanding drilling activities in Namibia, in a bid to bulk up its JORC resource.
Drilling will kick off later in the month at Tumas 3, with about 13,000 metres of RC drilling.
DYL shares have been trading at $1.61.
